Oric Pharmaceuticals, Inc. (ORIC) › Capital ExpendituresOric Pharmaceuticals, Inc. (ORIC) — Capital ExpendituresAnnual figures by fiscal year, from SEC filings.2018: $525.0K2019: $768.0K2020: $667.0K2021: $939.0K2022: $2.08M2023: $849.0K2024: $1.19M2025: $712.0K$712.0K2018Capital Expenditures (USD)2025Fiscal YearCapital ExpendituresChange YoY2025$712.0K-40.1%2024$1.19M+39.9%2023$849.0K-59.1%2022$2.08M+121.3%2021$939.0K+40.8%2020$667.0K-13.2%2019$768.0K+46.3%2018$525.0K—Other metrics: RevenueCost of RevenueGross ProfitOperating IncomeNet IncomeEPS (Diluted)Total AssetsTotal LiabilitiesShareholders' EquityCash & EquivalentsOperating Cash FlowShares OutstandingDividends Per Share